<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02023645</url>
  </required_header>
  <id_info>
    <org_study_id>2012-10516</org_study_id>
    <nct_id>NCT02023645</nct_id>
  </id_info>
  <brief_title>The Effects of a Carotenoid Intervention on Cognitive Function</brief_title>
  <official_title>The Effects of a Lutein + Zeaxanthin Intervention on Cognitive Function and Neural Efficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Georgia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>DSM Nutritional Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Georgia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Past research suggests that retinal lutein levels are related to cognitive function as
      measured via behavioral tests. The goal of the present study is to investigate the
      relationship between lutein and cognitive function in a wider variety of the population
      (young, healthy adults and older adults), using a wider variety of methods (behavioral
      testing and neuroimaging).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Past research suggests that retinal lutein levels are related to cognitive function as
      measured via behavioral tests. The goal of the present study is to investigate the
      relationship between lutein and cognitive function in a wider variety of the population
      (young, healthy adults and older adults), using a wider variety of methods (behavioral
      testing and neuroimaging).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>macular pigment optical density</measure>
    <time_frame>12 months</time_frame>
    <description>optical density of macular pigment layer in central retina, defined in log units of optical density</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum carotenoid levels</measure>
    <time_frame>12 months</time_frame>
    <description>serum carotenoids will be measured via high performance liquid chromatography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>reaction time</measure>
    <time_frame>12-months</time_frame>
    <description>reaction (msec) to a light stimulus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>executive function</measure>
    <time_frame>12-months</time_frame>
    <description>computerized composite score from computerized battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>short-term memory</measure>
    <time_frame>12-months</time_frame>
    <description>composite score from a computerized battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual attention</measure>
    <time_frame>12-months</time_frame>
    <description>composite score from computerized battery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Active supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 mg lutein + 2 mg zeaxanthin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>inert placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo for comparison</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>active supplement</intervention_name>
    <description>tablet</description>
    <arm_group_label>Active supplement</arm_group_label>
    <other_name>FloraGlo lutein</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>tablet</description>
    <arm_group_label>inert placebo</arm_group_label>
    <other_name>inert placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  visual acuity correctable to 20:40 or better, Snellen notation

          -  able to swallow a dietary supplement

          -  free of dementia, characterized by a score of less than 1.5 on the Clinical Dementia
             Rating Scale

        Exclusion Criteria:

          -  GI conditions that interfere with lipid absorption

          -  presence of or past diagnosis of age-related macular degeneration

          -  visual acuity poorer than 20:40, Snellen notation

          -  has taken lutein, omega-3 fatty acid or fish oil supplements within the last 6 months

          -  presence of dementia, characterized by a score of 1.5 or greater on the Clinical
             Dementia Rating Scale
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Billy R Hammond, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Georgia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The University of Georgia</name>
      <address>
        <city>Athens</city>
        <state>Georgia</state>
        <zip>30602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 16, 2013</study_first_submitted>
  <study_first_submitted_qc>December 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2013</study_first_posted>
  <last_update_submitted>May 26, 2015</last_update_submitted>
  <last_update_submitted_qc>May 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Georgia</investigator_affiliation>
    <investigator_full_name>Billy R. Hammond</investigator_full_name>
    <investigator_title>Professor and Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>lutein</keyword>
  <keyword>cognition</keyword>
  <keyword>neural efficiency</keyword>
  <keyword>aging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>April 13, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

